GPR3 Rabbit Polyclonal Antibody
Contact Us Below To Order :
 GPR3 Antibody |
|
1-CSB-PA209020 |
Cusabio |
|
|
|
|
|
Description: A polyclonal antibody against GPR3. Recognizes GPR3 from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB;ELISA:1:1000-1:5000, WB:1:200-1:1000 |
GPR3 Antibody |
|
1-CSB-PA009800LA01HU |
Cusabio |
|
|
|
|
|
Description: A polyclonal antibody against GPR3. Recognizes GPR3 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, IHC, IF; Recommended dilution: IHC:1:20-1:200, IF:1:50-1:200 |
GPR3 Antibody |
|
24899-100ul |
SAB |
100ul |
EUR 390 |
 GPR3 Antibody |
|
31211-100ul |
SAB |
100ul |
EUR 252 |
GPR3 Antibody |
|
31211-50ul |
SAB |
50ul |
EUR 187 |
GPR3 Antibody |
|
DF2736 |
Affbiotech |
200ul |
EUR 304 |
|
Description: GPR3 antibody detects endogenous levels of total GPR3. |
GPR3 Antibody |
|
5175-002mg |
ProSci |
0.02 mg |
EUR 171.82 |
|
|
|
Description: GPR3 Antibody: GPR3, also known as ACCA, is a G-protein coupled receptor that constitutively activates adenylate cyclase and is highly expressed in the central nervous system. Overexpression of GPR3 stimulates the production of amyloid-beta peptide (Abeta), the deposition of which is one of the pathological hallmarks of Alzheimer 's disease (AD), while the ablation of GPR3 prevented the accumulation of Abeta in vitro and in an AD mouse model. This is of particular interest because of the proximity of a reported candidate Alzheimer 's disease (AD) locus, suggesting that GPR3 may be a potential therapeutic target for the treatment of AD. GPR3 has also been shown to block the proliferation of cerebellar granule cell precursors (GCP) during postnatal development by inhibiting the Shh-induced proliferation of GCP, indicating that GPR3 activation may represent one of the signals that triggers the postnatal cell cycle exit and terminal differentiation of GPCs. |
GPR3 Antibody |
|
5175-01mg |
ProSci |
0.1 mg |
EUR 436.42 |
|
|
|
Description: GPR3 Antibody: GPR3, also known as ACCA, is a G-protein coupled receptor that constitutively activates adenylate cyclase and is highly expressed in the central nervous system. Overexpression of GPR3 stimulates the production of amyloid-beta peptide (Abeta), the deposition of which is one of the pathological hallmarks of Alzheimer 's disease (AD), while the ablation of GPR3 prevented the accumulation of Abeta in vitro and in an AD mouse model. This is of particular interest because of the proximity of a reported candidate Alzheimer 's disease (AD) locus, suggesting that GPR3 may be a potential therapeutic target for the treatment of AD. GPR3 has also been shown to block the proliferation of cerebellar granule cell precursors (GCP) during postnatal development by inhibiting the Shh-induced proliferation of GCP, indicating that GPR3 activation may represent one of the signals that triggers the postnatal cell cycle exit and terminal differentiation of GPCs. |
 GPR3 antibody |
|
20R-GR026 |
Fitzgerald |
50 ug |
EUR 656 |
|
Description: Rabbit polyclonal GPR3 antibody |
GPR3 antibody |
|
20R-GR027 |
Fitzgerald |
50 ug |
EUR 656 |
|
Description: Rabbit polyclonal GPR3 antibody |
 Polyclonal Goat Anti-GPR3 Antibody |
|
APR16282G |
Leading Biology |
0.1 mg |
EUR 484 |
|
Description: A polyclonal antibody raised in Goat that recognizes and binds to Human Goat Anti-GPR3 . This antibody is tested and proven to work in the following applications: |
) Polyclonal GPR3 Antibody (C-Terminus) |
|
APR16542G |
Leading Biology |
0.05mg |
EUR 484 |
|
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human GPR3 (C-Terminus). This antibody is tested and proven to work in the following applications: |
) Polyclonal GPR3 Antibody (Extracellular Domain) |
|
APR16544G |
Leading Biology |
0.05mg |
EUR 484 |
|
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human GPR3 (Extracellular Domain). This antibody is tested and proven to work in the following applications: |
Polyclonal GPR3 Antibody (Extracellular Domain) |
|
APR16545G |
Leading Biology |
0.05mg |
EUR 484 |
|
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human GPR3 (Extracellular Domain). This antibody is tested and proven to work in the following applications: |
Polyclonal GPR3 Antibody (Extracellular Domain) |
|
APR16546G |
Leading Biology |
0.05mg |
EUR 484 |
|
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human GPR3 (Extracellular Domain). This antibody is tested and proven to work in the following applications: |
 GPR3 Polyclonal Antibody, Biotin Conjugated |
|
A57915 |
EpiGentek |
100 µg |
EUR 570.55 |
|
Description: kits suitable for this type of research |
 GPR3 Polyclonal Antibody, FITC Conjugated |
|
A57916 |
EpiGentek |
100 µg |
EUR 570.55 |
|
Description: fast delivery possible |
 GPR3 Polyclonal Antibody, HRP Conjugated |
|
A57917 |
EpiGentek |
100 µg |
EUR 570.55 |
|
Description: reagents widely cited |
 Anti-GPR3 antibody |
|
STJ192628 |
St John's Laboratory |
200 µl |
EUR 197 |
|
Description: Unconjugated Rabbit polyclonal to GPR3 |
 anti- GPR3 antibody |
|
FNab03604 |
FN Test |
100µg |
EUR 585 |
|
|
|
Description: Antibody raised against GPR3 |
 GPR3 Conjugated Antibody |
|
C31211 |
SAB |
100ul |
EUR 397 |
 GPR3 siRNA |
|
20-abx918525 |
Abbexa |
|
|
|
|
GPR3 siRNA |
|
20-abx918526 |
Abbexa |
|
|
|
|
GPR3 siRNA |
|
20-abx902286 |
Abbexa |
|
|
|
|
 GPR3 Peptide |
|
46-669P |
ProSci |
0.1 mg |
EUR 338 |
|
Description: GPR3 Peptide |
GPR3 Peptide |
|
5175P |
ProSci |
0.05 mg |
EUR 164.75 |
|
Description: (CT) GPR3 peptide |
 GPR3 Antibody, HRP conjugated |
|
1-CSB-PA009800LB01HU |
Cusabio |
|
|
|
|
|
Description: A polyclonal antibody against GPR3. Recognizes GPR3 from Human. This antibody is HRP conjugated. Tested in the following application: ELISA |
GPR3 Rabbit Polyclonal Antibody
